Mirati Therapeutics, Inc. (NASDAQ:MRTX – Get Free Report) saw a significant drop in short interest in December. As of December 31st, there was short interest totalling 4,390,000 shares, a drop of 40.7% from the December 15th total of 7,400,000 shares. Based on an average trading volume of 2,150,000 shares, the short-interest ratio is presently 2.0 […]
Mirati Therapeutics (NASDAQ:MRTX) Coverage Initiated by Analysts at StockNews.com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Mirati Therapeutics, Inc. (NASDAQ:MRTX – Get Free Report) EVP Jamie Christensen sold 1,531 shares of the stock in a transaction dated Thursday, January 4th. The stock was sold at an average price of $58.81, for a total transaction of $90,038.11. Following the transaction, the executive vice president now directly owns 157,135 shares of the company’s […]
Mirati Therapeutics (NASDAQ:MRTX) Earns Sell Rating from Analysts at StockNews.com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Analysts Set Mirati Therapeutics, Inc. (NASDAQ:MRTX) Target Price at $59.60 etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.